NCT05770882 2025-03-11
Chidamide + Regorafenib in Hepatocellular Carcinoma (HCC)
Great Novel Therapeutics Biotech & Medicals Corporation
Phase 1/2 Terminated
Great Novel Therapeutics Biotech & Medicals Corporation
ImmunityBio, Inc.
Hoffmann-La Roche
UNICANCER